Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jan;64(1):53-63.
doi: 10.1016/j.jaad.2009.12.056. Epub 2010 Oct 30.

The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome

Affiliations
Comparative Study

The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome

Ming Yang Bi et al. J Am Acad Dermatol. 2011 Jan.

Abstract

Background: Alopecia can be a manifestation of mycosis fungoides (MF) and Sézary syndrome (SS), but the prevalence is unknown.

Objective: We sought to describe the clinicopathologic presentation and molecular features of alopecia in patients with MF/SS.

Methods: A retrospective chart review of a prospectively collected MF/SS database was used to identify patients with alopecia. The National Alopecia Areata Registry was used to identify patients with self-reported cutaneous T-cell lymphoma.

Results: Among 1550 patients with MF/SS, 38 patients with patchy, total-scalp, or universal alopecia were identified. Thirteen of 38 (34%) had patchy alopecia clinically identical to alopecia areata. Scalp biopsy specimens were available in 5 of the 13 patients. Specimens from 4 patients had atypical T lymphocytes within the follicular epithelium or epidermis, and that from two patients had a histology of follicular mucinosis. The remaining 25 of 38 (66%) patients with MF/SS included 20 with alopecia within discreet patch/plaque or follicular lesions of MF and 5 with total-body hair loss, which presented only in those with generalized erythroderma and SS.

Limitations: This was a retrospective study done at one cancer center. Biopsy specimens of alopecia were not available for every patient.

Conclusions: Alopecia was observed in 2.5% of patients with MF/SS, with alopecia areata-like patchy loss in 34% and alopecia within MF lesions in 66%.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources